Oxford BioMedica secures UK MHRA approval to manufacture drugs at new facilities
Oxford BioMedica has secured approvals from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for investigational medicinal products at its new facilities.
Click on this link for more information.
